A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer	Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Recruiting	Phase 4	2026-07-30		NCT06457503

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Coherus Oncology, Inc.	14

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Boston Medical Center	Boston	United States	200
Cleveland Clinic	Cleveland	United States	558
Emory Winship Cancer Institute	Atlanta	United States	29
Froedtert Hospital and the Medical College of Wisconsin	Milwaukee	United States	27
Henry Ford Cancer Center	Detroit	United States	4
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health	New York	United States	27
Penn State Milton S. Hershey Medical Center	Hershey	United States	44
Princess Margaret Cancer Centre	Toronto	Canada	1
University of Arkansas for Medical Sciences	Little Rock	United States	218
University of California, Irvine	Irvine	United States	32
University of California, San Francisco	San Francisco	United States	14
University of Cincinnati Medical Center	Cincinnati	United States	83
University of Michigan	Ann Arbor	United States	538